Success Metrics

Clinical Success Rate
66.7%

Based on 4 completed trials

Completion Rate
67%(4/6)
Active Trials
2(20%)
Results Posted
25%(1 trials)
Terminated
2(20%)

Phase Distribution

Ph not_applicable
7
70%
Ph phase_4
1
10%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Phase 4Post-market surveillance
1(12.5%)
N/ANon-phased studies
7(87.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

4 of 6 finished

Non-Completion Rate

33.3%

2 ended early

Currently Active

2

trials recruiting

Total Trials

10

all time

Status Distribution
Active(3)
Completed(4)
Terminated(2)
Other(1)

Detailed Status

Completed4
Recruiting2
Terminated2
Not yet recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
2
Success Rate
66.7%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (12.5%)
N/A7 (87.5%)

Trials by Status

recruiting220%
completed440%
not_yet_recruiting110%
unknown110%
terminated220%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
10